首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1622471

支架市场规模、份额、成长分析、按产品、按材料、按最终用户、按地区 - 行业预测，2025-2032 年

Stents Market Size, Share, Growth Analysis, By Product (Vascular, Non-Vascular Stents), By Material (Metallic Stents, Non-Metallic Stents), By End User, By Region - Industry Forecast 2025-2032

出版日期: 2024年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023年支架市场规模为93亿美元，从2024年的96.1亿美元成长到2032年的125亿美元，在预测期间（2025-2032年）复合年增长率为3.3%。

据 CDC 称，由于冠状动脉疾病盛行率上升，全球支架市场正在显着增长，该疾病导致 2019 年约 360,900 人死亡。这种快速增长的推动因素包括支架设计的技术进步、私人和政府对医疗保健发展的投资增加以及对药物释放型支架的需求不断增加。支架是维持阻塞动脉血流的重要医疗设备，不仅用于预防心血管疾病，也用于预防主动脉和大脑等重要部位的动脉瘤。一个显着的例子是中国医药于2021年8月在欧洲推出HT Supreme药物释放型支架，凸显了该行业的持续创新和对患者需求的回应能力。

市场概况
血管
- 冠状动脉支架
- 周边设备支架
- 髂动脉支架
- 股动脉支架
- 颈动脉支架
- 肾动脉支架
- 其他周边设备支架
- 神经血管支架
- 颅内支架
- 分流器
非血管支架
- 胃肠支架
- 胆道
- 十二指肠
- 冒号
- 胰臟
- 食道支架
- 肺（气道）支架
- 硅胶气道
- 金属气道
- 泌尿系统支架
- 其他的

支架市场规模：依材料划分

市场概况
金属支架
非金属支架

支架市场规模：依最终用户划分

市场概况
医院
专科诊所
门诊手术中心
其他的

支架市场规模

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2022-2024）

主要企业简介

Boston Scientific
Medtronic
Abbott Laboratories
Terumo Corporation
Johnson & Johnson
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Cook Medical
MicroPort Scientific Corporation
Sahajanand Medical Technologies
Alvimedica
Biosensors International
Lepu Medical Technology
Meril Life Sciences
Balton Sp. z oo
Translumina Therapeutics
Vascular Concepts
Relisys Medical Devices
Endocor GmbH
Hexacath

结论和建议

简介目录

Product Code: SQMIG35A2607

Stents Market size was valued at USD 9.3 Billion in 2023 and is poised to grow from USD 9.61 Billion in 2024 to USD 12.5 Billion by 2032, growing at a CAGR of 3.3% during the forecast period (2025-2032).

The global stents market is witnessing significant growth driven by the rising prevalence of coronary artery disease, which led to approximately 360,900 deaths in 2019, according to the CDC. This surge is propelled by technological advancements in stent design, heightened investment from both private and government sources into healthcare development, and an escalating demand for drug-eluting stents. Stents, essential medical devices that maintain blood flow in blocked arteries, are increasingly being utilized not only for cardiovascular diseases but also for preventing aneurysms in critical areas like the aorta and brain. A notable example includes the European launch of the HT Supreme Drug-eluting stent by Sinomed in August 2021, highlighting the industry's continuous innovation and response to patient needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stents Market Segmental Analysis

Global Stents Market is segmented by product, material, end user and region. Based on product, the market is segmented into vascular and non-vascular stents. Based on material, the market is segmented into metallic stents and non-metallic stents. Based on end user, the market is segmented into hospitals, specialty clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stents Market

The stent market is significantly driven by the increasing global incidence of cardiovascular diseases (CVDs), which is anticipated to enhance market growth in the coming years. The rise in chronic disease cases is leading to greater demand for procedures such as percutaneous coronary interventions and peripheral vascular surgeries. The World Health Organization (WHO) reports that cardiovascular diseases result in approximately 17.9 million deaths annually, representing around 32% of all global fatalities. As the number of individuals affected by cardiovascular conditions continues to grow, it will inevitably heighten the need for stents, thereby propelling market demand.

Restraints in the Stents Market

One significant restraint on the stents market is the rigorous regulatory environment that hinders its growth potential. Various regulatory agencies, including the FDA, enforce stringent guidelines and requirements for the safe and effective use of stents. The FDA's thorough evaluation process necessitates a careful review of existing literature and pre-clinical animal studies prior to granting approval. This process is often resource-intensive, demanding considerable time and financial investment, particularly as coronary stents are classified as category III devices. Additionally, the classification of stents as medium to high-risk medical devices subjects them to stringent regulatory compliance, ultimately dampening market demand due to the complexity and costs associated with obtaining necessary approvals.

Market Trends of the Stents Market

The stents market is witnessing significant growth driven by continuous innovations and refinements in product design. Key advancements focus on optimizing stent features, such as reducing strut thickness, enhancing deliverability in complex vascular anatomies, and introducing a variety of lengths and diameters. Recent breakthroughs, like the FDA-approved Xience Sierra in 2018, emphasize enhanced flexibility and smaller profiles for improved performance during percutaneous coronary interventions (PCI). These developments aim to enhance patient outcomes and reduce procedural complications, thereby fueling market expansion. As healthcare providers increasingly adopt these advanced stent technologies, the market is poised for robust growth in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Trade Analysis

Global Stents Market Size by Product & CAGR (2025-2032)

Market Overview
Vascular
- Coronary Stents
- Peripheral Stents
- Iliac Artery Stents
- Femoral Artery Stents
- Carotid Artery Stents
- Renal Artery Stents
- Other Peripheral Stents
- Neurovascular Stents
- Intracranial Stents
- Flow Diverters
Non-Vascular Stents
- Gastrointestinal Stents
- Biliary
- Duodenal
- Colonic
- Pancreatic
- Esophageal Stents
- Pulmonary (Airway) Stents
- Silicone Airway
- Metallic Airway
- Urological Stents
- Others

Global Stents Market Size by Material & CAGR (2025-2032)

Market Overview
Metallic Stents
Non-Metallic Stents

Global Stents Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Others

Global Stents Market Size & CAGR (2025-2032)

North America (Product, Material, End User)
- US
- Canada
Europe (Product, Material, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sahajanand Medical Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alvimedica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balton Sp. z o.o.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Translumina Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Concepts
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Relisys Medical Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endocor GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hexacath
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments